Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Clinical trial NCT06045299 · COMPLETED
Trial details
- NCT number
- NCT06045299
- Sponsor
- Corxel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2024-08-19
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.